New molecules and treatment modulation in advanced prostatic cancer.

Suppr

超能文献

作者信息

Mahler C, Verhelst J, Denis L

机构信息

Dept. Endocrinology, Oncologic Centre Antwerp, A.Z. Middelheim, Antwerp, Belgium.

出版信息

Acta Urol Belg. 1996 May;64(2):95-8.

PMID:8701825

Abstract

摘要

相似文献

New molecules and treatment modulation in advanced prostatic cancer.

Acta Urol Belg. 1996 May;64(2):95-8.

The place and the results of monotherapy.

Acta Urol Belg. 1998 May;66(2):11-5.

Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

J Urol. 2004 Aug;172(2):774; author reply 774-5. doi: 10.1097/01.ju.0000132508.20023.08.

[Antiandrogen in prostate cancer].

Nihon Rinsho. 2002 Dec;60 Suppl 11:188-92.

[Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].

Urologiia. 2002 Sep-Oct(5):23-6.

[Preliminary results of casodex use in patients with hormone-resistant cancer of the prostate].

Urologiia. 2001 Nov-Dec(6):20-1.

New drug for prostate cancer.

Eur J Cancer Care (Engl). 2001 Jun;10(2):79-80.

[Total androgen blockade].

Nihon Rinsho. 2002 Dec;60 Suppl 11:193-8.

[The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].

Urol Nefrol (Mosk). 1997 May-Jun(3):49-52.

Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.

J Urol. 2008 Sep;180(3):921-7. doi: 10.1016/j.juro.2008.05.045. Epub 2008 Jul 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

New molecules and treatment modulation in advanced prostatic cancer.

Acta Urol Belg. 1996 May;64(2):95-8.

The place and the results of monotherapy.

Acta Urol Belg. 1998 May;66(2):11-5.

Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.

J Urol. 2004 Aug;172(2):774; author reply 774-5. doi: 10.1097/01.ju.0000132508.20023.08.

[Antiandrogen in prostate cancer].

Nihon Rinsho. 2002 Dec;60 Suppl 11:188-92.

[Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].

Urologiia. 2002 Sep-Oct(5):23-6.

[Preliminary results of casodex use in patients with hormone-resistant cancer of the prostate].

Urologiia. 2001 Nov-Dec(6):20-1.

New drug for prostate cancer.

Eur J Cancer Care (Engl). 2001 Jun;10(2):79-80.

[Total androgen blockade].

Nihon Rinsho. 2002 Dec;60 Suppl 11:193-8.

[The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].

Urol Nefrol (Mosk). 1997 May-Jun(3):49-52.

Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.

J Urol. 2008 Sep;180(3):921-7. doi: 10.1016/j.juro.2008.05.045. Epub 2008 Jul 17.